Regenicin, Inc. — Operating Income by Fiscal Year
12 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/5731af06-ddde-46bb-86a9-65e13be1b850/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $-635.9k | 2020-10-01 – 2021-09-30 | evidence 0001662252-22-000007 |
| FY 2020 | $-510.8k | 2019-10-01 – 2020-09-30 | evidence 0001662252-21-000002 |
| FY 2019 | $-736.6k | 2018-10-01 – 2019-09-30 | evidence 0001662252-20-000003 |
| FY 2018 | $-540.3k | 2017-10-01 – 2018-09-30 | evidence 0001662252-19-000010 |
| FY 2017 | $-961.1k | 2016-10-01 – 2017-09-30 | evidence 0001662252-18-000011 |
| FY 2016 | $-779.9k | 2015-10-01 – 2016-09-30 | evidence 0001662252-17-000017 |
| FY 2015 | $-241.8k | 2014-10-01 – 2015-09-30 | evidence 0001662252-16-000036 |
| FY 2014 | $-725.9k | 2013-10-01 – 2014-09-30 | evidence 0001255294-15-000024 |
| FY 2013 | $-11.6M | 2007-09-06 – 2014-03-31 | evidence 0001255294-14-000467 |
| FY 2012 | $-7.6M | 2007-09-06 – 2013-03-31 | evidence 0001255294-13-000388 |
| FY 2011 | $-6.4M | 2007-09-06 – 2012-03-31 | evidence 0001255294-12-000338 |
| FY 2010 | $-679.1k | 2009-10-01 – 2010-09-30 | evidence 0001255294-12-000013 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).